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Abstract
Background: Helping cancer survivors to transition from active treatment to long-term survivorship requires
coordinated efforts by both oncologists and primary care physicians (PCPs). This study aims to evaluate cancer
survivors’ perspectives on PCP-delivered survivorship care.
Methods: We conducted an Internet-based cross-sectional survey of cancer survivors via www.OncoLink.org.
Regression analyses were used to identify factors associated with perception of PCP-delivered survivorship care.
Results: The 352 respondents rated overall PCP-delivered survivorship care as 60 out of 100 (SD = 23). The areas of
care most strongly endorsed were general care (62 %), psychosocial support (65 %), and holistic care (68 %).
Survivors were less likely to perceive their PCPs as knowledgeable about cancer follow-up (43 %), late or long-term
effects of cancer therapy (45 %), and diagnosis and treatment of symptoms related to cancer or cancer therapy
(42 %). While 72 % of survivors reported satisfaction with their PCP’s care overall, only 41 % felt that their PCPs and
oncologists communicated well with one another. In a multivariate regression analysis, higher trust in PCP (p <
0.001), non-white race (p = 0.001), living in the United States (p = 0.007), and visiting a PCP two or more times per
year (p = 0.009) were significantly associated with higher ratings of PCP-delivered survivorship care.
Conclusions: While cancer survivors in general are satisfied with care delivery by PCPs, they perceived that their
PCPs have limited abilities in performing cancer-specific follow-up and late effect monitoring and treatment. Better
education of family physicians about survivorship issues and improved communication between PCPs and
oncologists are needed to improve PCPs’ delivery of survivorship care.
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Background
With improved surveillance, early detection, and treat-
ment of cancer, the number of cancer survivors living
beyond the active treatment phase is increasing in the
United States. As of 2007, there were 12 million cancer
survivors living in the United States, up from 9.8 million
in 2001 and 3 million in 1971. The largest groups of can-
cer survivors were female breast cancer survivors (22.1 %),
prostate cancer survivors (22.1 %), and colorectal cancer
survivors (9.5 %) [1]. As cancer survivors live decades
beyond their initial cancer diagnosis, they are at risk for
developing a number of physical and psychosocial
conditions and late or long-term effects that are inde-
pendent of their cancer or treatment. Survivors may
experience chronic pain, fatigue, sleep problems, cog-
nitive issues, sexual dysfunction, ongoing depression/
distress, fear of recurrence, and changes in their over-
all quality of life [2]. Studies in breast cancer survi-
vors have found high prevalence of these symptoms
among survivors [3–6]. Lung, colon, and prostate
cancer survivors have also reported significant and
persistent physical, psychosocial, sexual, and marital
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problems for years after disease remission that signifi-
cantly impact their quality of life [7].
Traditionally, cancer patients receive healthcare through
medical, surgical, or radiation oncologists for issues that
arise during active cancer treatment and the initial post-
treatment surveillance period. Thus, these providers have
been thought of as the first line in addressing survivors’
needs when cancer-related or treatment-related sequelae
arise. However, studies show that while cancer survivors
visit oncologists frequently during active treatment, the
percentage of survivors who visit oncologists and cancer-
related specialists declines each year following active treat-
ment. While survivors visit their oncologists less and less
as time passes, the percentage of survivors who visit their
primary care physician (PCP) each year is consistently
high at around 75 % and does not decline as survivors get
further out from initial diagnosis [8, 9]. This means that as
time progresses, the vast majority of cancer survivors will
present to their PCPs instead of their oncologists for
evaluation and management of late and long-term effects.
The PCP can play a critical role in the management of a
cancer survivor’s health by delivering preventive and gen-
eral care as well as managing co-morbid conditions that
may be unrelated to the cancer. Consequently, a team ef-
fort is required in order to assure that relevant informa-
tion regarding cancer treatment, surveillance schedule,
and general survivorship issues is communicated to the
PCP by the oncology team [10].
Unfortunately, the transition of care from oncology to
primary care is often fragmented and uncoordinated. A
2005 Institute of Medicine (IOM) report revealed that
many cancer survivors felt uncertain about the care they
receive once they transition from the care of their oncol-
ogists at the end of their cancer treatment course. Con-
sequently, the IOM recommended a cancer treatment
survivorship care plan for cancer survivors during the
transition period that outlines information for long-term
care including cancer diagnosis, treatment, potential
consequences of treatment and guidelines for follow-up
visits, general tips on healthy living and prevention of
new and recurrent cancers, and the availability of psy-
chosocial and legal support services [11]. Interestingly,
research done to date demonstrates that family physi-
cians are able to provide care that is similar in quality
and outcomes as that provided by oncology specialists
for breast cancer survivors [12]. However, a recent
study found that survivorship care planning did not
improve patient-reported outcomes and health care
service utilization compared to standard care in the
same type of population [13, 14]. In order to deliver
the comprehensive, coordinated care suggested by the
IOM, PCPs must become more comfortable with the
delivery of cancer survivorship care. Since 2005, several
surveys of primary care physicians and oncologists have
been conducted which indicate that both PCPs and
oncologists acknowledge the importance of primary care
physician involvement in new models of survivorship care
delivery and are willing to work toward improving the
transition of care [15–21].
While it is important to understand the views of PCPs
and oncologists regarding the transfer of cancer survivor-
ship care from primarily oncology-based to PCP-based, it
is vital to incorporate cancer survivor perspectives as we
move toward designing and implementing new models of
patient-centered survivorship care. To date, few studies
have examined cancer survivor perspectives on the deliv-
ery of survivorship care by primary care physicians. The
few studies of survivor perspectives of PCP-delivered
survivorship care have focused primarily on patients
presenting to urban or university-affiliated cancer cen-
ters [22–24]. In this study, we used an Internet-based
survey to quantify cancer survivor perspectives of PCP-
delivered survivorship care. Our aim in using an
Internet-based survey was to gather information from
more geographically diverse groups of cancer survivors
underrepresented in the current literature.
Methods
Study design and respondent population
Between July 2009 and June 2012, an Internet-based
questionnaire assessing patient demographics and percep-
tions of primary care physician-delivered survivorship care
was intermittently (few days every few months) posted on
the OncoLink website (http://www.oncolink.org). Onco-
Link, one of the oldest and largest Internet-based cancer
information resources, serves close to 1.5 million web
pages and receives more than 189,000 visits from unique
IP addresses per month. OncoLink is available to anyone
who has access to the Internet. Currently, 75 % of Onco-
Link’s user base is from the United States, while 25 % ac-
cess the website from international locations [25].
The study questionnaire was composed of 30 items
assessing patient demographics, primary cancer diag-
noses, treatment modalities used, setting of cancer
treatment, use of primary care and specialty care, rela-
tionship with primary care physician and perceptions
of survivorship care delivery by primary care physi-
cians. The questionnaire was randomly rotated on the
homepage and other high profile locations on the web-
site. There was no use of external advertising or
directed e-mail announcements. Study participants
voluntarily and anonymously completed the survey in-
strument after reading an online informed consent
document. Survey questions and responses were main-
tained on a physically and electronically secure server
and downloaded for analysis. This cross-sectional
study was approved by the University of Pennsylvania
Institutional Review Board.
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Primary outcome measure
The primary outcome measure was a seven-item Primary
Care Delivery of Survivorship Care Scale (PCDSCS) [24].
Each item on the PCDSCS is scored on a 5-point Likert
scale from 0 to 4. The scale scores had an excellent in-
ternal consistency with a Cronbach’s alpha of 0.89. Princi-
pal component analysis yielded one factor with eigenvalue
of 3.89. The higher score was correlated with greater trust
in PCPs. The total score was transformed and placed on a
100-point scale with higher number indicating better per-
ceived care delivery by PCPs [24].
Covariates
Respondents reported demographic, cancer-related, and
healthcare-related variables. Demographic variables in-
cluded age, sex, race, educational level, residential area,
and country of residence. Cancer-related variables in-
cluded type of cancer, type of treatment (s) received, and
age at cancer diagnosis. Healthcare-related variables in-
cluded type of physician managing care, whether the re-
spondent has been offered survivorship care, distance to
and setting of the respondent’s cancer treatment center,
and length and frequency of relationship with their pri-
mary care physician. Respondents also rated communi-
cation between their PCP and oncologist and trust that
their PCP works toward the respondent’s best interests
as a patient. Trust in PCP was rated on a numerical
scale from 1 to 10 with 10 indicating highest trust. Be-
cause this variable was not normally distributed, we di-
chotomized at the median value as high vs. low trust.
Statistical analysis
Statistical analysis was performed using STATA 12.0 for
Windows (STATA Corp, College Station, TX). Bivariate
regression analysis was used to select patient characteris-
tics associated with the outcome variable, PCDSCS. Var-
iables that showed a strong association (p < 0.1) were
then used to generate a multivariate regression model to
further characterize patient variables associated with per-
ceived survivorship care delivery by PCPs. All analyses
were two-sided with p < 0.05 indicating statistical signifi-
cance. Chi-square analyses of individual PCDSCS state-
ment endorsement were performed to determine which
aspects of PCP survivorship care delivery might explain
significant differences observed between groups in multi-
variate regression. Respondents were considered to en-
dorse a particular aspect of PCP survivorship care delivery
if they answered “Agree” or “Strongly agree” in response
to the corresponding item on the survey instrument.
Results
Respondent characteristics
The mean age for the 352 cancer survivors who
responded to the Internet survey was 54.1 years. Two
hundred and ninety-three respondents (83.5 %) were fe-
male and 58 (16.5 %) were male. Racially, 277 (79.8 %)
were Caucasian, 36 (10.4 %) were Asian or Pacific
Islander, 15 (4.3 %) were African-American, 9 (2.6 %)
were Hispanic or Latino, 6 (1.7 %) were of mixed race,
and 4 (1.2 %) considered themselves to be of another
race. One hundred and thirty-six (39.3 %) lived in urban
areas, 151 (43.6 %) lived in suburban areas, and 59
(17.1 %) lived in rural areas. Two hundred and thirty-
two (66.5 %) respondents held a college degree (BA, BS)
or higher. Respondents included survivors of thirty dif-
ferent cancer types. Of these, 149 (43.1 %) were breast
cancer survivors, 19 (5.5 %) were lung cancer survivors,
18 (5.2 %) were colon cancer survivors, 15 (4.3 %) re-
ported a history of ovarian cancer, and 11 (3.2 %) were
prostate cancer survivors. One hundred and thirty-
seven (39.9 %) received cancer care exclusively at
university-based cancer centers, while 150 (43.7 %) re-
ported receiving cancer care at community-based non-
university affiliated centers. Two hundred and eighty-
two respondents (81.5 %) were living in the United
States, 8 (2.3 %) were living in Canada, and 56 (16.2 %)
reported living in sixteen other countries. Respondents
living in the United States were from forty of the fifty
states and represented all four census regions of the
country. Of the 243 respondents who indicated their
state of residence, 88 (36.2 %) were from the Northeast,
63 (25.9 %) were from the West, 57 (23.5 %) were from
the South, and 35 (14.4 %) were from the Midwest. For
data analysis purposes, race was dichotomized as
Caucasian or non-Caucasian and cancer type was di-
chotomized as breast or non-breast to enhance the
power when analyzing these variables.
Respondent rating of Primary Care Delivery of
Survivorship Care Scale (PCDSCS)
Overall, respondents rated primary care physician deliv-
ery of survivorship care 59.8 out of 100 (median 60.7,
SD 22.7). Respondents most strongly endorsed primary
care physician delivery of holistic care (66.8 %), psycho-
social support (64.2 %), and general care (61.1 %) that
enables patients to live healthier lives. Respondents were
less likely to perceive PCPs as knowledgeable in the fol-
lowing domains of care: appropriate cancer follow-up
care (42.3 %), late or long-term effects of cancer therapy
(44.3 %), and diagnosis and treatment of symptoms re-
lated to cancer or cancer therapy (41.8 %). Only 40.3 %
of respondents believed that their PCP communicates
well with their oncologists in managing their care. Re-
spondent trust in their PCP was high with a mean of
7.54 and a median of 8 (SD 2.64). Trust scores ranged
from 0 to 10, with 30.11 % of respondents rating trust
in their PCP as 10 out of 10.
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Respondent characteristics associated with PCDSCS score
Table 1 shows the distribution of respondents and
PCDSCS scores. In bivariate analysis, non-white race
(p = 0.004), US residence (p = 0.001), and history of ra-
diation therapy (p = 0.018) were significantly associated
with higher PCDSCS scores. More frequent PCP visits
(p = 0.002), higher trust in PCP (p < 0.001), and per-
ceiving the PCP as one of the people with primary re-
sponsibility for patient care (p < 0.001) were also
associated with higher PCDSCS scores. Interestingly,
the setting of cancer treatment and type of cancer
(breast or non-breast) were not significantly associated
with PCDSCS rating.
In multivariate analysis, non-white race, US residence,
and having two or more visits with the PCP annually
were significantly associated with higher PCDSCS score
(p = 0.001, 0.007 and 0.009 respectively). Higher trust in
PCP was strongly associated with higher PCDSCS score
(p < 0.001, Fig. 1). Table 2 depicts the results of multi-
variate regression analysis.
Respondent Endorsement of Individual Aspects of PCDSCS
(Table 3)
Chi-square analysis showed significant differences be-
tween white respondents and non-white respondents in
perceived cancer-specific care; scores on general care
and communication with oncologists did not differ sig-
nificantly by race. United States residents were signifi-
cantly more likely to agree that their PCP helps them
live a healthier life by discussing diet and exercise weight
management, but did not differ significantly from non-
US residents in the endorsement of other statements on
PCP delivery of survivorship care. High trust in PCP
showed the strongest relationship with individual statement







18–39 69 21.2 57.8
40–64 203 62.5 58.6
65 or older 53 16.3 61.9
Gender 0.92
Male 58 16.5 59.6
Female 293 83.5 60.0
Race 0.0035
White 277 79.8 58.1
Non-White 70 20.2 67.0
Education level 0.32





Urban 136 39.3 63.1
Suburban 151 43.6 56.8
Rural 59 17.1 59.1
Country 0.0007
United States 282 81.5 61.8
Outside United States 64 18.5 51.1
Cancer type 0.75
Breast 149 43.1 60.3
Non-breast 197 56.9 59.5
Cancer center 0.65
University-based 137 39.9 58.6
Community-based 150 43.7 61.1
Both 56 16.3 59.7
Chemotherapy 0.55
Yes 196 57.0 60.8
No 148 43.0 59.3
Radiation therapy 0.018
Yes 168 48.8 57.1
No 176 51.2 63.0
Surgery 0.088
Yes 212 61.6 58.5
No 132 38.4 62.8
Hormone therapy 0.36
Yes 106 30.8 58.4
No 238 69.2 60.9
PCP visits per year 0.0015
Fewer than 2 101 28.9 53.6
Table 1 PCDSCS Score and Respondent Characteristics
(Continued)
2 or more 248 71.1 62.2
Trust in PCP <0.001
Low 138 39.2 43.5
Higher 214 60.8 70.3
Care providers 0.059
PCP/Internist 68 21.3 63.6
Oncologist 124 38.9 57.5
Combination 127 39.8 63.6
Years known PCP 0.008
Less than 1 year 63 18.5 52.5
1–4 years 108 31.8 64.6
5–9 years 76 22.4 60.3
10 or more years 93 27.4 58.5
Abbreviations: PCDSCS primary care delivery of survivorship care scale, PCP
primary care physician, BA/BS bachelor of arts or bachelor of science
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endorsement; respondents reporting higher trust in their
PCP rated all aspects of PCP care delivery significantly
higher than respondents reporting lower trust in their PCP.
Discussion
Although there is much interest in the literature on con-
structing new models of cancer survivorship care, few
studies have quantified cancer patients’ perspectives of
survivorship care by primary care physicians who are the
principal caretakers of cancer survivors after the initial
treatment and surveillance period. We found that survi-
vors generally believe that their PCPs provide high qual-
ity primary care, psychosocial support, and holistic care,
which is consistent with a prior trial demonstrating that
breast cancer survivors had high satisfaction with their
PCPs [26] and experienced a similar health-related qual-
ity of life as if they were cared by specialists [12]. How-
ever survivors were less confident in their PCPs’ ability
to provide knowledgeable, appropriate cancer-specific
care. These findings are consistent with previous studies
of breast and prostate cancer survivors[24, 27], empha-
sizing the need for improving education for PCPs on
cancer-specific follow up care.
This study found that non-white patients and patients
who visit their PCP more frequently rate PCP delivery of
survivorship care significantly higher. The association
between non-white race and PCDSCS score may be ex-
plained by differences among white patients and minor-
ity patients in what they consider to be important
components of quality healthcare. A recent study shows
that while patients of all racial groups perceive short
waiting times, good patient-provider rapport, physician
competence, and respect for the patient as important
components of quality healthcare, minority patients also
cited holistic care that addresses their physical, spiritual,
and emotional needs as an important component of
quality healthcare [28]. While, the provision of holistic
or whole-person care as opposed to disease or organ-
specific care may be more appreciated by non-white pa-
tients and may contribute to higher ratings of the
PCDSCS score, our results also show that non-white pa-
tients rate PCP delivery of cancer-specific care more
highly than white patients, a finding that calls for further
exploration.
The relationship between PCDSCS score and the fre-
quency of visits to the primary care physician can be
explained in several ways. More frequent visits with the
PCP allow more opportunities for building trust and
rapport between patients and their PCP, which likely
explains some of our observed association. Further-
more, the literature shows that more frequent PCP
visits may be associated with receipt of more appropri-
ate care, which would increase patient satisfaction. For
example, a study of prostate cancer patients showed
that patients who visited their PCP more frequently
were more likely to receive influenza vaccinations, colo-
rectal cancer screening, and cholesterol screening at
recommended intervals [29].
An interesting new finding of this study is the signifi-
cantly higher rating of PCDSCS by survivors living in
the United States when compared with those living out-
side the US. While there may be differences in percep-
tions of what constitutes high quality care in different
countries [30], this finding merits further study if we
hope to design successful models of patient-centered
survivorship care that will be applicable worldwide.
Given that each country has unique health care delivery
and health service reimbursement systems, it is likely
one size won’t fit all. However, the importance of trust
between a physician and patient transcends cultures and
health systems. Our study found that survivors generally
trust their primary care physicians. If educational sys-
tems or institutions provide pathways for PCPs to in-
crease their knowledge of cancer-specific follow-up,
surveillance, and diagnosis and treatment of late effects,
the high level of trust survivors have in their PCPs will
Fig. 1 Relationship between PCDSCS score and trust in PCP
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do much to advance survivor acceptance and increase
survivor perceptions of PCP-delivered survivorship care.
Overall, this study indicates that cancer survivors have
unfavorable perceptions of cancer-specific survivorship
care delivered by PCPs. This finding is consistent with
previous studies [19, 24, 27, 31] which show that al-
though PCPs are willing to assume more responsibility
for cancer survivorship care, they themselves feel that
their training and familiarity with cancer surveillance
guidelines are inadequate [16, 19, 20, 31–33]. Inter-
vention studies have shown that survivorship care
algorithms [12] and survivorship care courses [34] sig-
nificantly improve PCP comfort with, and delivery of,
appropriate cancer survivorship care. Future research
should focus on developing models for training both
upcoming and practicing PCPs in survivorship care
delivery that can be implemented in various practice
settings. Further studies should help elucidate the ef-
fect of this training on patient perceptions of PCP sur-
vivorship care delivery.
Several limitations to our study need to be acknowl-
edged. First, this cross-sectional study relies on survivor
Table 2 Multivariate Regression Analysis of Respondent Characteristics and PCDSCS Score
Unadjusted analysis Adjusted analysis
Characteristic Coefficient 95 % CI P-value Coefficient 95 % CI P-value
Race
Caucasian (reference)
Non-Caucasian 8.93 2.95 to 14.91 0.004 9.74 3.9 to 15.6 0.001
Residence
Urban (reference)
Suburban −6.32 −11.6 to −1.0 0.019 −2.00 −6.5 to 2.5 0.39
Rural −3.96 −10.9 to 3.0 0.26 −1.65 −7.8 to 4.5 0.60
Country
United States (reference)
Outside United States −10.71 −16.8 to −4.6 0.001 −7.94 −13.6 to −2.2 0.007
Radiation therapy
Yes −5.86 −10.7 to −1.0 0.018 −3.88 −8.0 to 0.3 0.069
No (reference)
Surgery
Yes −4.34 −9.3 to 0.6 0.088 −1.88 −6.4 to 2.6 0.41
No (reference)
PCP visits per year
Fewer than 2 (reference)
2 or more 8.57 3.3 to 13.8 0.002 6.22 1.6 to 10.9 0.009
Trust in PCP
Low (reference)
High 26.81 22.8 to 30.8 <0.001 26.47 22.1 to 30.8 <0.001
Care provider
PCP only (reference)
Oncologist only −6.14 −12.8 to 0.5 0.07 −4.91 −10.2 to 0.4 0.070
Both PCP and Oncologist −0.01 −6.6 to 6.6 1.00 −3.04 −8.4 to 2.3 0.26
Years known PCP
Less than 1 year (reference)
1-4 years 12.16 5.1 to 19.2 0.001 2.78 −3.2 to 8.7 0.36
5-9 years 7.85 0.4 to 15.3 0.04 −0.70 −7.2 to 5.8 0.83
10 or more years 6.04 −1.1 to 13.2 0.099 −5.04 −11.6 to 1.5 0.13
Abbreviations: PCDSCS primary care delivery of survivorship care scale, PCP primary care physician
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self-report instead of directly measuring PCP survivor-
ship care delivery. Secondly, the use of an Internet-based
survey creates selection bias in our study; cancer survi-
vors who are over the age of 60, minorities, or those
who have lower education are less likely to have Internet
access and are expected to be under-sampled and under-
represented in Internet-based research studies [35, 36].
Our research needs to be replicated in representative
clinical or population based samples. Lastly, although
our survey respondents have very heterogeneous tumor
types and geographic representations, the smaller sample
size in each of the specific categories prevents more in-
depth comparison among subgroups.
Conclusions
Despite its limitations, to our knowledge, this is the first
Internet-based study of patient perspectives of cancer
survivorship care delivery by primary care physicians.
Through the use of a freely accessible Internet survey,
our study allows for representation of cancer survivor
populations that are otherwise under-represented in the
current literature (e.g. in community setting, with non-
breast cancer, rural, and other countries) on cancer sur-
vivorship care. The high trust between survivors and
their PCPs builds a strong foundation towards optimal
care. While cancer survivors in general are satisfied with
care delivery by PCPs, they perceived that their PCPs
have limited abilities in performing cancer-specific
follow-up and late effect monitoring and treatment.Our
findings highlight that equipping PCPs with cancer-
specific knowledge, skills, and confidence is necessary to
deliver high quality care for diverse groups of cancer
survivors.
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